Tuesday, November 21, 2017
 
 
News: Page (1) of 1 - 04/19/12 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
EU clears J&J's $21.3BN acquisition of Synthes
EU clears J&J's $21.3BN acquisition of Synthes after J&J promises to sell trauma unit
By The Associated Press

BRUSSELS (AP) ' The European Union's competition regulator says it has approved Johnson & Johnson's $21.3 billion acquisition of Swiss orthopedics maker Synthes.

The European Commission said Thursday J&J's promise to sell its trauma business ensured "the merged entity would continue to face competition" and left doctors and patients with a sufficient choice of alternatives.

Competition Commissioner Joaquin Almunia said the sale of the trauma business would be for the "benefit of patients and social security systems."



U.S. health care conglomerate J&J moved to buy Synthes last year in its biggest ever acquisition. It hoped the deal would help offset declines in sales from some of its biggest over-the-counter medicines.


Page: 1


 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines